Ad is loading...
IMMVF
Price
$0.15
Change
-$0.00 (-0.00%)
Updated
Feb 8 closing price
LZAGF
Price
$578.92
Change
-$31.73 (-5.20%)
Updated
Nov 15 closing price
Ad is loading...

IMMVF vs LZAGF

Header iconIMMVF vs LZAGF Comparison
Open Charts IMMVF vs LZAGFBanner chart's image
Immunovia AB
Price$0.15
Change-$0.00 (-0.00%)
Volume$325
CapitalizationN/A
Lonza Group AG
Price$578.92
Change-$31.73 (-5.20%)
Volume$25
CapitalizationN/A
IMMVF vs LZAGF Comparison Chart
Loading...
View a ticker or compare two or three
VS
IMMVF vs. LZAGF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMVF is a Hold and LZAGF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (IMMVF: $0.15 vs. LZAGF: $578.92)
Brand notoriety: IMMVF and LZAGF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IMMVF: 100% vs. LZAGF: 27%
Market capitalization -- IMMVF: $4.96M vs. LZAGF: $43.14B
IMMVF [@Medical Specialties] is valued at $4.96M. LZAGF’s [@Medical Specialties] market capitalization is $43.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMVF’s FA Score shows that 0 FA rating(s) are green whileLZAGF’s FA Score has 1 green FA rating(s).

  • IMMVF’s FA Score: 0 green, 5 red.
  • LZAGF’s FA Score: 1 green, 4 red.
According to our system of comparison, LZAGF is a better buy in the long-term than IMMVF.

Price Growth

IMMVF (@Medical Specialties) experienced а 0.00% price change this week, while LZAGF (@Medical Specialties) price change was -7.22% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.10%. For the same industry, the average monthly price growth was +5.35%, and the average quarterly price growth was -5.08%.

Industries' Descriptions

@Medical Specialties (+3.10% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
LZAGF($43.1B) has a higher market cap than IMMVF($4.96M). LZAGF YTD gains are higher at: 38.167 vs. IMMVF (-11.765). LZAGF has higher annual earnings (EBITDA): 1.42B vs. IMMVF (-146.67M). LZAGF has more cash in the bank: 2.15B vs. IMMVF (68.2M). IMMVF has less debt than LZAGF: IMMVF (35.9M) vs LZAGF (2.91B). LZAGF has higher revenues than IMMVF: LZAGF (6.32B) vs IMMVF (1.48M).
IMMVFLZAGFIMMVF / LZAGF
Capitalization4.96M43.1B0%
EBITDA-146.67M1.42B-10%
Gain YTD-11.76538.167-31%
P/E RatioN/A32.79-
Revenue1.48M6.32B0%
Total Cash68.2M2.15B3%
Total Debt35.9M2.91B1%
FUNDAMENTALS RATINGS
LZAGF: Fundamental Ratings
LZAGF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
58
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRCVX4.10-0.01
-0.24%
Comstock Capital Value A
ABCAX24.00-0.11
-0.46%
American Beacon The London Co Inc Eq A
JPDVX16.03-0.12
-0.74%
JPMorgan Diversified L
ICISX17.67-0.15
-0.84%
VY® Columbia Small Cap Value II I
FDFIX25.09-0.33
-1.30%
Fidelity Flex 500 Index

IMMVF and

Correlation & Price change

A.I.dvisor tells us that IMMVF and IDTA have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMVF and IDTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMVF
1D Price
Change %
IMMVF100%
N/A
IDTA - IMMVF
8%
Poorly correlated
N/A
LZAGF - IMMVF
8%
Poorly correlated
-5.20%
LZAGY - IMMVF
6%
Poorly correlated
-7.61%
IRME - IMMVF
4%
Poorly correlated
N/A
IOBCF - IMMVF
0%
Poorly correlated
N/A
More

LZAGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LZAGF has been loosely correlated with LZAGY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if LZAGF jumps, then LZAGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LZAGF
1D Price
Change %
LZAGF100%
-5.20%
LZAGY - LZAGF
61%
Loosely correlated
-7.61%
SAUHF - LZAGF
30%
Poorly correlated
-1.51%
TRXO - LZAGF
29%
Poorly correlated
N/A
TCHBF - LZAGF
28%
Poorly correlated
N/A
SAUHY - LZAGF
28%
Poorly correlated
-1.84%
More